Janus kinase inhibitor compounds and methods
US8486950B2 · kind B2 · utility
23Cited by
4References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 10, 2010 |
| Grant date | Jul 16, 2013 |
| Priority date | — |
| Expiry date | Nov 4, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compounds of Formula I, stereoisomers or pharmaceutically acceptable salts thereof, wherein A, B, D, R1, R2, R4 and R5 are defined herein, a pharmaceutical composition that includes a compound of Formula I and methods of use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.